Early outcomes and the virologic impact of delayed treatment switching on second-line therapy in an antiretroviral roll-out program in South Africa

Ítems similars

• Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa
  per: Levison, Julie H., et al.
  Publicat: (2012)
• Resistance in Pediatric Patients Experiencing Virologic Failure with First- and Second-Line Antiretroviral Therapy
  per: Orrell, Catherine, et al.
  Publicat: (2013)
• Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression
  per: Nglazi, Mweete D., et al.
  Publicat: (2013)
• Increased Mortality with Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa
  per: Gorrod, Helen Bell, et al.
  Publicat: (2020)
• Virologic failure and second-line antiretroviral therapy in children in South Africa - The IeDEA Southern Africa Collaboration
  per: Davies, Mary-Ann, et al.
  Publicat: (2011)